| Sign In to gain access to subscriptions and/or personal tools. |
Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro modelInstitute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Blindern
Department of Pharmacology, School of Pharmacy, Blindern
Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo
Department of Immunology and Transfusion Medicine, Institute of Laboratory Medicine, The Regional Hospital, Norwegian Institute for Science and Technology, Trondheim
Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo
Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo
Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo
Department of Immunology and Transfusion Medicine, Nordland Central Hospital, Bodø and University of Tromsø, Oslo
Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo
Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo
Transplantation Services, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, Texas
Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo We studied the effects of bypass circuit surface heparinization on kallikrein-kinin, coagulation, fibrinolytic and complement activation in a closed model system for simulating veno-venous bypass (VVBP) in orthotopic liver transplantation (OLT). The circuits were identical to those in routine use during clinical OLT in our institution. Fresh whole human blood diluted 1: 2 with Ringers acetate was circulated at a non-pulsatile flow (2 l/min) and at a constant temperature (37.5°C) for 12 h. In 10 experiments, the entire inner surface of the circuits was coated with end-point attached heparin (HC). In the remaining 10, non-treated PVC tubing was used (NC). Components of the plasma kallikrein-kinin, coagulation, fibrinolytic and complement systems were analyzed using functional techniques (chromogenic peptide substrate assays) and enzyme immunoassays at baseline, 3 and 12 h.
Significant activation of the initial (C3bc) and terminal (TCC) components of the complement system were found in both the NC and HC groups after 3 and 12 h: C3bc: NC: baseline =4 (3.5-7.7), 3 h=17.3* (12.5-27), 12 h=31* (17.7-63.6), HC: baseline=4.9 (3.2-6.8), 3 h=9* (6-14.4), 12 h=13.7* (7.4-18.1). TCC: NC: baseline=0.4 (0.2-0.6), 3 h=5* (0.8-11.9), 12 h: 13.1* (4.2-25.7). HC: baseline=0.5 (0.1-0.6), 3 h=0.6* (0.1-0.8), 12 h=1.2* (0.3-2) AU/ml; median and range (*: p<0.05). The C3bc and TCC concentrations were significantly higher in the NC group at 3 and 12 h, compared to the HC group: C3bc (NC vs. HC group): 3 h,p<0.001; 12 h, p<0.001. TCC (NC vs. HC group): 3 h, p<0.001; 12 h, p<0.001. Significant increases in the values of thrombin-antithrombin complexes (p<0.003), prothrombin fragment 1+2 (p<0.006) and plasmin- We conclude that heparin-coating of the internal surface of the extracorporeal perfusion circuit used for VVBP reduces activation of the plasma cascade systems in a closed venous system in vitro.
Perfusion, Vol. 16, No. 4,
285-292 (2001) |
|||
2-antiplasmin complexes (p=0.016) were found in the non-coated group, but not in the heparin-coated group during the observation period, showing that the coagulation and fibrinolytic systems were activated in the non-coated circuits.